annual CFF:
$606.67M+$473.13M(+354.30%)Summary
- As of today (July 1, 2025), VERA annual cash flow from financing activities is $606.67 million, with the most recent change of +$473.13 million (+354.30%) on December 31, 2024.
- During the last 3 years, VERA annual CFF has risen by +$552.79 million (+1025.93%).
- VERA annual CFF is now at all-time high.
Performance
VERA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.53M-$324.42M(-99.53%)Summary
- As of today (July 1, 2025), VERA quarterly cash flow from financing activities is $1.53 million, with the most recent change of -$324.42 million (-99.53%) on March 31, 2025.
- Over the past year, VERA quarterly CFF has dropped by -$275.01 million (-99.45%).
- VERA quarterly CFF is now -99.53% below its all-time high of $325.95 million, reached on December 31, 2024.
Performance
VERA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$331.67M-$275.01M(-45.33%)Summary
- As of today (July 1, 2025), VERA TTM cash flow from financing activities is $331.67 million, with the most recent change of -$275.01 million (-45.33%) on March 31, 2025.
- Over the past year, VERA TTM CFF has increased by +$29.57 million (+9.79%).
- VERA TTM CFF is now -45.33% below its all-time high of $606.67 million, reached on December 31, 2024.
Performance
VERA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VERA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +354.3% | -99.5% | +9.8% |
| 3 y3 years | +1025.9% | -98.1% | +147.2% |
| 5 y5 years | +10000.0% | -69.1% | +5840.6% |
VERA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1025.9% | -99.5% | +3093.8% | -45.3% | +289.1% |
| 5 y | 5-year | at high | >+9999.0% | -99.5% | +1730.8% | -45.3% | +5942.4% |
| alltime | all time | at high | >+9999.0% | -99.5% | +1730.8% | -45.3% | +6577.4% |
VERA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.53M(-99.5%) | $331.67M(-45.3%) |
| Dec 2024 | $606.67M(+354.3%) | $325.95M(>+9900.0%) | $606.67M(+98.6%) |
| Sep 2024 | - | $739.00K(-78.5%) | $305.55M(+0.1%) |
| Jun 2024 | - | $3.44M(-98.8%) | $305.10M(+1.0%) |
| Mar 2024 | - | $276.54M(+1013.8%) | $302.10M(+126.2%) |
| Dec 2023 | $133.54M(+31.0%) | $24.83M(+8259.6%) | $133.54M(+3.2%) |
| Sep 2023 | - | $297.00K(-31.3%) | $129.42M(-0.5%) |
| Jun 2023 | - | $432.00K(-99.6%) | $130.03M(+0.3%) |
| Mar 2023 | - | $107.98M(+421.4%) | $129.65M(+27.2%) |
| Dec 2022 | $101.93M | $20.71M(+2180.7%) | $101.93M(+18.3%) |
| Sep 2022 | - | $908.00K(+1791.7%) | $86.14M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $48.00K(-99.9%) | $85.24M(-36.5%) |
| Mar 2022 | - | $80.27M(+1531.1%) | $134.18M(+149.0%) |
| Dec 2021 | $53.88M(-36.8%) | $4.92M(>+9900.0%) | $53.88M(-58.2%) |
| Sep 2021 | - | $0.00(-100.0%) | $128.76M(+0.1%) |
| Jun 2021 | - | $48.99M(<-9900.0%) | $128.67M(+60.2%) |
| Mar 2021 | - | -$28.00K(-100.0%) | $80.30M(-5.9%) |
| Dec 2020 | $85.29M(<-9900.0%) | - | - |
| Dec 2020 | - | $79.80M(<-9900.0%) | $85.29M(+1453.8%) |
| Sep 2020 | - | -$94.00K(-115.3%) | $5.49M(-1.7%) |
| Jun 2020 | - | $616.00K(-87.6%) | $5.58M(+12.4%) |
| Mar 2020 | - | $4.97M | $4.97M |
| Dec 2019 | -$137.00K | - | - |
FAQ
- What is Vera Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Vera Therapeutics?
- What is Vera Therapeutics annual CFF year-on-year change?
- What is Vera Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Vera Therapeutics?
- What is Vera Therapeutics quarterly CFF year-on-year change?
- What is Vera Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Vera Therapeutics?
- What is Vera Therapeutics TTM CFF year-on-year change?
What is Vera Therapeutics annual cash flow from financing activities?
The current annual CFF of VERA is $606.67M
What is the all time high annual CFF for Vera Therapeutics?
Vera Therapeutics all-time high annual cash flow from financing activities is $606.67M
What is Vera Therapeutics annual CFF year-on-year change?
Over the past year, VERA annual cash flow from financing activities has changed by +$473.13M (+354.30%)
What is Vera Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of VERA is $1.53M
What is the all time high quarterly CFF for Vera Therapeutics?
Vera Therapeutics all-time high quarterly cash flow from financing activities is $325.95M
What is Vera Therapeutics quarterly CFF year-on-year change?
Over the past year, VERA quarterly cash flow from financing activities has changed by -$275.01M (-99.45%)
What is Vera Therapeutics TTM cash flow from financing activities?
The current TTM CFF of VERA is $331.67M
What is the all time high TTM CFF for Vera Therapeutics?
Vera Therapeutics all-time high TTM cash flow from financing activities is $606.67M
What is Vera Therapeutics TTM CFF year-on-year change?
Over the past year, VERA TTM cash flow from financing activities has changed by +$29.57M (+9.79%)